Moderna Inc. MRNA will have its experimental mRNA-based flu vaccine reviewed by a Food and Drug Administration (FDA) advisory ...
Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
Feb 11 (Reuters) - A U.S. Food and Drug Administration ⁠official ⁠on Wednesday defended the agency's surprise decision ⁠to not review Moderna's experimental flu vaccine application, saying the company ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. Subscribe to read this story ...
Every year, flu vaccines are updated to match the flu viruses expected to circulate. For 2026, the vaccine focuses on several influenza strains that research predicts will be most prevalent. This ...
Influenza A H3N2 subclade K has driven flu cases across the country, with 52 counties in Florida seeing increases over the past week. While the current flu vaccine might be a "mismatch," it still ...
How bad will the 2025-2026 flu season be? The exact timing, duration and severity of flu seasons vary each year and can only really be understood in retrospect, explains Robert Amler, MD, MMS, MBA, ...
It's winter and with the holidays near, the 2025-2026 flu season has hit the U.S. with flu cases on the rise in New Jersey, with doctors urging those who haven't gotten the flu shot to do so now.